Skip to main content

Table 3 Postoperative outcomes regarding complications and knee function

From: Comparison of oral versus intra-articular tranexamic acid in enhanced-recovery primary total knee arthroplasty without tourniquet application: a randomized controlled trial

Variable

Oral TXA Group

IA TXA Group

P value

Postop. Complications (%)a

2 (2.7%)

1 (1.3%)

0.76

 DVT

1

0

0.51

 PE

0

0

–

 Superficial infection

0

0

–

 Hematoma

0

1

0.50

 Wound secretion

1

0

0.51

 Gastric hemorrhage

0

0

–

Postop. knee functionb

 QoR-40b

  1 M

181.9 ± 5.4

183.4 ± 6.6

0.11

  3 M

189.4 ± 5.9

190.1 ± 3.4

0.34

 ROM b

  1 M

113.9 ± 8.7

112.6 ± 8.2

0.37

  3 M

122.4 ± 10.4

124.4 ± 9.13

0.17

 Pain scoreb

  POD 1

4.2 ± 2.3

4.5 ± 1.5

0.39

  POD 3

2.4 ± 1.4

2.6 ± 1.5

0.37

  3 M

1.4 ± 1.1

1.3 ± 1.2

0.71

 KSS b

84.6 ± 4.8

85.9 ± 7.1

0.18

 Knee circumference (cm)b

  Upper pole of patella

41.2 ± 3.2

41.8 ± 6.0

0.46

  Lower pole of patella

35.5 ± 2.4

36.0 ± 3.2

0.28

All cause 30-day mortalitya

0

0

–

All cause 90-day readmissiona

0

0

–

  1. ROM range of motion, QoR-40 quality of life-40, DVT deep vein thrombosis, PE pulmonary embolism, KSS knee society score
  2. aData are presented as number of patients with percentage
  3. bData are presented as Mean ± standard deviation